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Infections in Stem Ce[[ Transp[ant Recipients $25 
Methods: Recipient C57Bt/6 mice received 13Gy 
of totat body irradiation and were rescued with BM 
obtained from femurs of donor C57Bt/6 mice. Res- 
ident AMs and recruited tung PMNs were harvested 
3 to 5 weeks post-BMT and their eicosanoid profite 
were examined. We measured the Fc and non-Fc 
mediated phagocytosis and kitting of AMs and PMNs 
post-BMT. Indomethacin, a PG inhibitor, was used 
to brock PGE2 production in vitro and in vivo. 
Results: BMT AMs produce 125-times more PGE2 
than controt AMs and BMT PMNs produce 27-ford 
more PGE2 than controt PMNs. We have shown that 
the increased susceptibitity of BMT mice corretates 
with defective AM phagocytosis and kitting of Gram- 
negative bacteria. Interestingty, PMNs from BMT 
mice do not disptay defective phagocytosis, but 
do show a defect in their abitity to kitt ingested 
Gram-negative bacteria. The pharmacotogic btock- 
ade of prostagtandin production by indomethacin in 
vitro restores AM phagocytosis and kitting and PMN 
kitting. In addition, treatment with indomethacin 
restores host defense to P. aeruginosa in vivo. 
Conclusions: We show that eicosanoid dysregu- 
ration post-BMT inhibits the effectiveness of the 
innate immune response. Inhibiting PGs in vitro and 
in vivo restores impaired putmonary host defense 
post-BMT. 
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Increased Susceptibility to Gammaherpesvirus 
Post-Bone Marrow Transplantation 
T.R. McMittan*, M.N. Battinger, B.B. Moore. 
University of Michigan, Ann Arbor, MI, USA 
Background: Bone marrow transptantation (BMT) 
is used in the treatment of various matignan- 
cies. The success of BMT is timited by muttipte 
comptications inctuding putmonary infections both 
pre-engraftment and after engraftment has oc- 
curred. We previousty demonstrated that mice af- 
ter BMT have an increased susceptibitity to Gram- 
negative bacteriat pneumonia after engraftment. 
This appears to be due to impaired tung innate 
immunity with defective phagocytosis in atveo- 
tar macrophages, and defective kitting in tung 
neutrophits. Response to vaccination is dimin- 
ished in patients post-BMT indicating that there 
are adaptive immune defects as wett. To fur- 
ther etucidate the adaptive immune defects in 
rungs post-BMT, we anatyzed a tung infection with 
muMne gammaherpesvirus-68 (MHV-68). MHV-68 is 
a ds-DNA virus that is most simitar to Epstein 
Barr virus (EBV) and Kaposi sarcoma-associated 
herpesvirus (KSHV) in humans. 
Objective: Our hypothesis is that dysregutation in 
the adaptive immune response in the rungs post- 
BMT reads to increased susceptibitity to virat in- 
fection. 
Methods: Syngeneic BMT was performed in recip- 
ient C57Bt/6 mice receiving 13Gy of totat body 
irradiation, rescued with bone marrow obtained 
from the femurs of donor C57Bt/6 mice. Con- 
trot (untransptanted) and BMT mice were infected 
with 5x104 ptaque forming units (PFUs) MHV-68 
intranasatty at 6 weeks post-BMT. PFUs were mea- 
sured from tung homogenates at days 3, 5, 7, 9, 
and 14 post-infection. Cett counts and differentiats 
were performed and tymphocyte subsets were an- 
atyzed with flow cytometry. Cytokine revers were 
measured using ELISA. 
Results: Mice that have undergone BMT have 25- 
times the PFUs at day 7 post-infection versus con- 
trot mice. There is an increase in the percentage 
of neutrophits, and a decrease in tymphocytes in 
BMT mice versus controt mice. There is a decrease 
in the percentage of CD8+ T-cetts, but no change 
in CD4+ T-cetts, B-cetts, or NK cetts. There is no 
difference in TNF atpha revers in BMT versus controt 
mice post infection. White IFN-gamma increased in 
controt mice, no increase was seen in BMT mice 
post infection. 
Conclusion: Mice post-BMT have an increased sus- 
ceptibitity to [ytic tung infection with MHV-68 after 
futt engraftment has occurred. This finding is tikety 
retated to both innate and adaptive immune de- 
fects. 
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Background & Objectives: The cytomegalovirus 
(CMV) gtycoprotein B (gB) is the major envetope 
gtycoprotein, encoded by the UL55 gene. Based on 
sequence variation in the UL55 gene, CMV can be 
ctassified into four gB genotypes. Previous studies 
have suggested there coutd be an association be- 
tween CMV gB genotype and ctinica[ outcome in 
the immunocompromised hosts. The goat of this 
study was to determine the distribution of CMV 
gB genotypes and the effect of gB genotype in 
the devetopment of CMV diseases in hematopoietic 
stem cet[ transptant (HSCT) recipients in Korea. 
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Methods: DNA was extracted from 91 serum sam- 
pies of 52 a[[ogeneic HSCT recipients with CMV 
infection. CMV gB genotype was determined using 
po[ymerase chain reaction to amplify a region of 
UL55, foLLowed by restriction analysis based on Rsal 
and Hinfl digestion. 
Results: The distribution of gB types were as 
foLLows: gB1, 73.1% (38/52) of patients; gB2, 
13.5% (7/52); gB3, 1.9% (1/52) and mixed infection 
(gB1 and gB2), 9.6% (5/52). WhiLe gB4 was not 
detected, a new genotype (described as gB7 by 
Trincado eta[, 2000), defined on the basis of their 
restriction fragment Length po[ymorphism pattern, 
was identified. During 2-year foLLow up period, CMV 
diseases developed in 5 patients. ALL of them had 
been infected with gB1 genotype. There was no 
statisticaLLy significant association between the in- 
cidence of CMV diseases and the gB genotypes. Re- 
infection with gB1 strain was detected in a patient 
who had been previously infected with gB2. This 
episode was associated with fever, elevated Liver 
enzyme and positive antigenemia. 
Conclusion: CMV gB1 was the dominant genotype 
and gB4 was not detected in a[[ogeneic HSCT recip- 
ients in Korea. This is a unique pattern to compare 
with other reports. ALthough we can not find sig- 
nificant association between the CMV diseases and 
the gB genotypes, genotyping of CMV wiLL serve in 
the study of pathogenesis and transmission of this 
virus in the transplant patients. Further study is on 
going with Large study population. 
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Comparison of Galactomannan EIA and 
Quantitative PCR Performed on BAL Fluid for 
Diagnosing of Invasive Pulmonary Aspergillosis 
in HSCT Recipients 
A. Upton, W. Leisenring, M. Boeckh, K.A. Marr*. 
Fred Hutchinson Cancer Research Center, 
Seattle, WA, USA 
Background: Invasive pulmonary asper~iUosis (IPA) 
is a Life-threatening complication of hematopoietic 
stem ceLL transplantation (HSCT). ALthough timely 
diagnosis is often thwarted by the sub-optimaL sen- 
sitivity and specificity of conventional diagnostic 
tests, recent advances such as the ga[actomannan 
(GM) EIA and PCR assays are encouraging. 
Objectives: The aim of this study was to determine 
the sensitivity, specificity, and positive and nega- 
tive predictive values of the GM EIA and a Light- 
CycLer based quantitative PCR assay performed on 
broncho-aLveoLar [avage (BAL) fluid for diagnosing 
IA foLLowing HSCT. 
Methods: AduLt HSCT recipients undergoing bron- 
choscopy and BAL between 1st Dec 2003 and 
30th Sept 2005 were included. A GM index of 
~>0.5 was considered positive. CLinicaL data were 
coLLected by chart review. Each bronchoscopy with 
BAL was considered an episode. Positive assays 
from patients with proven or probable IA at the 
time of BAL were considered 'true-positives' while 
those from patients without IA were considered 
'faLse-positives'. Episodes of possible IA were ex- 
cluded from further analysis. 
Results: 150 patients with 211 episodes were ana- 
Lyzed. Proven, probable, possible and no IA was di- 
agnosed in 3, 29, 82, and 97 episodes, respectively. 
Performance as an aid to diagnose IPA (proven or 
probable) using the GM EIA and PCR assay were, 
respectiveLy: sensitivity 53% and 53%, specificity 
94% and 100%, positive predictive value: 74% and 
100%, and negative predictive value: 86% and 87%. 
When either a positive GM EIA or PCR assay was 
considered to be a positive test, the sensitivity, 
specificity, positive and negative predictive values 
were 69%, 94%, 79%, and 90%, respectively. 22 of 
the 32 proven or probable episodes of IA had cuL- 
ture negative BAL fluid. Of these, PCR was positive 
in 8, and GM EIA positive in 10 episodes. Thus, 
performing the GM EIA and PCR assay on BAL fluid 
increased the percentage of positive microbiology 
results by 32% and 24%, respectively. 
Conclusions: ALthough the GM and PCR assays, 
when performed on BAL fluid in high-risk patients, 
are not sufficiently sensitive to replace culture, 
they are useful adjunctive tests in making a diag- 
nosis of IPA and improve the sensitivity of culture 
alone. Combining the two tests increases the sen- 
sitivity, while maintaining exceLLent specificity. 
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Background & Methods: Epstein-Barr virus (EBV) 
associated post transplantation [ymphopro[ifera- 
tive disorder (PTLD) has emerged as an increas- 
ing cause of high morbidity and mortality in solid 
organ and bone marrow transplant (BMT) recipi- 
ents, particuLarLy in children. CLinicaL presentation 
